ThreatsDay Bulletin tracks active exploits, phishing waves, AI risks, major flaws, and cybercrime crackdowns shaping this week’s threat landscape.

Antibody therapies can remove amyloid plaques from the brain and slow cognitive decline in people with Alzheimer's disease ...

This week - the enterprise has a newfound obsession with "quality data" - but are we on the wrong track for AI? Pega and HubSpot turn in strong earnings, but Wall Street's AI fever (dreams?) persist.